Anest. intenziv. Med. 2013;24(3):183-185

Kidney and composition of infusion solutions. Reason for cautionSpecial article

Matějovič Martin
I. interní klinika, UK v Praze, LF v Plzni a FN Plzeň

Intravenous fluid therapy is one of the cornerstones of critical illness management. Surprisingly, only very recently findings have suggested that clinicians carefully consider the type, amount and rate of administration of the resuscitation fluids. Indeed, long-awaited studies have been published over the past 12 months, enabling the clinicians to make better decisions which solution to choose from the large menu on offer. This article is a brief commentary on the most recent studies demonstrating the distinct effects of intravenous fluids on the renal physiology and function in critical care and peri-operative medicine.

Keywords: fluid therapy; critical care; renal physiology; peri-operative medicine

Published: June 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Matějovič M. Kidney and composition of infusion solutions. Reason for caution. Anest. intenziv. Med. 2013;24(3):183-185.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Perner, A. et al. 6S Trial Group, Scandinavian Critical Care Trials Group Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N. Engl. J. Med., 2012, 367, 2, p. 124-134. Go to original source... Go to PubMed...
    2. Myburgh, J. A. et al., CHEST Investigators, Australian and New Zealand Intensive Care Society Clinical Trials Group Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N. Engl. J. Med., 2012, 367, 20, p. 1901-1911. Go to original source... Go to PubMed...
    3. Shaw, A. D., Kellum, J. A. The Risk of AKI in Patients Treated with Intravenous Solutions Containing Hydroxyethyl Starch. Clin. J. Am. Soc. Nephrol., 2013 [Epub ahead of print]. Go to original source... Go to PubMed...
    4. Antonelli, M., Sandroni, C. Hydroxyethyl starch for intravenous volume replacement: more harm than benefit. JAMA, 2013, 309, 7, p. 723-724. Go to original source... Go to PubMed...
    5. Patel, A., Waheed, U., Brett, S. J. Randomised trials of 6 % tetrastarch (hydroxyethyl starch 130/0.4 or 0.42) for severe sepsis reporting mortality: systematic review and meta-analysis. Intensive Care Med., 2013, [Epub ahead of print]. Go to original source... Go to PubMed...
    6. Haase, N., Perner, A., Hennings, L. I., Siegemund, M., Lauridsen, B., Wetterslev, M., Wetterslev, J. Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis. BMJ, 2013, 346, p. f839. Go to original source... Go to PubMed...
    7. Zarychanski, R., Abou-Setta, A. M., Turgeon, A. F., Houston, B. L., McIntyre, L., Marshall, J. C., Fergusson, D. A. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis. JAMA, 2013, 309, 7, p. 678-688. Go to original source... Go to PubMed...
    8. Yunos, N. M., Bellomo, R., Hegarty, C., Story, D., Ho, L., Bailey, M.Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA, 2012, 308, 15, p. 1566-1572. Go to original source... Go to PubMed...
    9. Shaw, A. D., Bagshaw, S. M., Goldstein, S. L., Scherer, L. A., Duan, M., Schermer, C. R., Kellum, J. A. Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared to Plasma-Lyte. Ann. Surg., 2012, 255, 5, p. 821-829. Go to original source... Go to PubMed...
    10. Wilcox, C. S. Regulation of renal blood flow by plasma chloride. J. Clin. Invest., 1983, 71, p. 726-735. Go to original source... Go to PubMed...
    11. Chowdhury, A. H., Cox, E. F., Francis, S. T., Lobo, D. N. A randomized, controlled, double-blind crossover study on the effects of 2-L infusions of 0.9% saline and plasma-lyte® 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers. Ann. Surg., 2012, 256, p. 18-24. Go to original source... Go to PubMed...

    Return to the content


    Anesteziologie a intenzivní medicína

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.